UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Preclinical Pharmacology of the Taxanes: Implications of the Differences

The oncologist (Dayton, Ohio), 2004-06, Vol.9 (S2), p.3-8

2004

Volltextzugriff (PDF)

Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy

Journal of clinical oncology, 2010-11, Vol.28 (33), p.4906-4911

2010

Volltextzugriff (PDF)

Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study

Annals of oncology, 2004-09, Vol.15 (9), p.1339-1343

2004

Volltextzugriff (PDF)

Classification of and Risk Factors for Estrogen Deprivation Pain Syndromes Related to Aromatase Inhibitor Treatments in Women With Breast Cancer: A Prospective Multicenter Cohort Study

The journal of pain, 2014-03, Vol.15 (3), p.293-303

2014

Volltextzugriff (PDF)

Global Curriculum Edition 2016: European Society for Medical Oncology/American Society of Clinical Oncology Recommendations for Training in Medical Oncology

Journal of clinical oncology, 2017-01, Vol.35 (2), p.254-255

2017

Volltextzugriff (PDF)

1032 Strong association between pathological response to neoadjuvant chemotherapy, TILs and modeled CA125 KELIM in ovarian carcinomas: CHIVA trial, GINECO

International journal of gynecological cancer, 2021-10, Vol.31 (Suppl 3), p.A340-A340

2021

Volltextzugriff (PDF)

Impact of molecular genotyping on the diagnosis and treatment of human chorionic gonadotropin-producing tumors

Journal of gynecology obstetrics and human reproduction, 2024-01, Vol.53 (1), p.102704-102704, Article 102704

2024

Volltextzugriff (PDF)

CPT-11 (Irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer

European journal of cancer (1990), 1999-09, Vol.35 (9), p.1343-1347

1999

Volltextzugriff (PDF)

Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)

European journal of cancer (1990), 1999-09, Vol.35 (9), p.1338-1342

1999

Volltextzugriff (PDF)

Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer

International journal of radiation oncology, biology, physics, 1999, Vol.43 (1), p.25-38

1999

Volltextzugriff (PDF)

4CPS-121 Impact of pharmaceutical consultations for new oral oncology agents

European journal of hospital pharmacy. Science and practice, 2018-03, Vol.25 (Suppl 1), p.A98-A98

2018

Volltextzugriff (PDF)

High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7)

European journal of cancer (1990), 2001-05, Vol.37 (8), p.1000-1005

2001

Volltextzugriff (PDF)

Prognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patients

British journal of cancer, 2006-02, Vol.94 (4), p.473-480

2006

Volltextzugriff (PDF)

Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial

Annals of oncology, 2005-03, Vol.16 (3), p.411-418

2005

Volltextzugriff (PDF)

The ESMO/ASCO Global Curriculum and the evolution of medical oncology training in Europe

ESMO open, 2016, Vol.1 (1), p.e000004-e000004, Article e000004

2016

Volltextzugriff (PDF)

Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer

Annals of oncology, 2000-11, Vol.11 (11), p.1477-1483

2000

Volltextzugriff (PDF)

A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patients

Annals of oncology, 2006-03, Vol.17 (3), p.429-436

2006

Volltextzugriff (PDF)

High-dose chemotherapy with haematopoietic stem cell transplantation for metastatic breast cancer patients: final results of the French multicentric randomised CMA/PEGASE 04 protocol

European journal of cancer (1990), 2005, Vol.41 (1), p.71-80

2005

Volltextzugriff (PDF)

[18F]FDG in recurrent breast cancer: diagnostic performances, clinical impact and relevance of induced changes in management

European journal of nuclear medicine and molecular imaging, 2004-02, Vol.31 (2), p.179-188

2004

Volltextzugriff (PDF)

Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study

International journal of radiation oncology, biology, physics, 2000-03, Vol.46 (4), p.903-911

2000

Volltextzugriff (PDF)

High-dose chemotherapy for ovarian carcinoma: Long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)

Annals of oncology, 2001-05, Vol.12 (5), p.693-699

2001

Volltextzugriff (PDF)

High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)

Bone marrow transplantation (Basingstoke), 2005-07, Vol.36 (1), p.25-31

2005

Volltextzugriff (PDF)

Severe neuropathy after high dose carboplatin in three patients receiving multidrug chemotherapy

Journal of neurology, neurosurgery and psychiatry, 1998-05, Vol.64 (5), p.667-669

1998

Volltextzugriff (PDF)

Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas: the ITOV 01 protocol

Bone marrow transplantation (Basingstoke), 2006-04, Vol.37 (7), p.669-675

2006

Volltextzugriff (PDF)

Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre study

Bone marrow transplantation (Basingstoke), 2006-04, Vol.37 (7), p.651-659

2006

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(65)

Publikationsform

Sprache

Englisch
(64)
Französisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(61)
Life Sciences & Biomedicine
(58)
Humans
(51)
Oncology
(45)
Female
(36)
Adult
(33)
Biological And Medical Sciences
(33)
Medical Sciences
(33)
Middle Aged
(31)
Male
(24)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(20)
Aged
(17)
Chemotherapy
(16)
Tumors
(15)
Combined Modality Therapy
(14)
Pharmacology. Drug Treatments
(13)
Prognosis
(13)
Adolescent
(11)
Antineoplastic Agents
(11)
Treatment Outcome
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Preclinical Pharmacology of the Taxanes: Implications of the Differences

Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy

Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study

Classification of and Risk Factors for Estrogen Deprivation Pain Syndromes Related to Aromatase Inhibitor Treatments in Women With Breast Cancer: A Prospective Multicenter Cohort Study

Global Curriculum Edition 2016: European Society for Medical Oncology/American Society of Clinical Oncology Recommendations for Training in Medical Oncology

1032 Strong association between pathological response to neoadjuvant chemotherapy, TILs and modeled CA125 KELIM in ovarian carcinomas: CHIVA trial, GINECO

Impact of molecular genotyping on the diagnosis and treatment of human chorionic gonadotropin-producing tumors

CPT-11 (Irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer

Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)

Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer

4CPS-121 Impact of pharmaceutical consultations for new oral oncology agents

High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7)

Prognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patients

Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial

The ESMO/ASCO Global Curriculum and the evolution of medical oncology training in Europe

Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer

A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patients

High-dose chemotherapy with haematopoietic stem cell transplantation for metastatic breast cancer patients: final results of the French multicentric randomised CMA/PEGASE 04 protocol

[18F]FDG in recurrent breast cancer: diagnostic performances, clinical impact and relevance of induced changes in management

Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study

High-dose chemotherapy for ovarian carcinoma: Long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)

High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)

Severe neuropathy after high dose carboplatin in three patients receiving multidrug chemotherapy

Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas: the ITOV 01 protocol

Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre study

Suchergebnisse filtern